Pacific Bio (PACB) – Analyst Ratings
-
Guggenheim Starts Pacific Biosciences of California (PACB) at Neutral
-
Stephens Starts Pacific Biosciences of California (PACB) at Overweight, 'Disruptive Technology in High-Growth Long-Read Sequencing Market'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PACB Stock Lookup